Differential Protein and Gene Expression in Endocrine and Neuroendocrine Tumors (NET)

Recruiting

• Conditions: C25.4; D35; Malignant neoplasm of small intestine; Neoplasm of uncertain or unknown behaviour of endocrine glands; Malignant neoplasm of other endocrine glands and related structures; C17; D44; C75; Endocrine pancreas; Benign neoplasm of other and unspecified endocrine glands

• Registration Number: DRKS00010117
• Lead Sponsor: niversitätsmedizin der Johannes Gutenberg-Universität Mainz

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-03-14
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

Patients who underwent surgery due to (neuro)endocrine tumors

Exclusion Criteria

//

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Disease associated Proteins and Genes

Secondary Outcome Measures

Name	Time	Method
Identification of markers with prognostic significance